These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9864091)

  • 1. Evaluation of the Emu-pim-1 transgenic mouse model for short-term carcinogenicity testing.
    van Kreijl CF; van der Houven van Oordt CW; Kroese ED; Sørensen IK; Breuer ML; Storer RD
    Toxicol Pathol; 1998; 26(6):750-6. PubMed ID: 9864091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term carcinogenesis bioassay of genotoxic procarcinogens in PIM transgenic mice.
    Storer RD; Cartwright ME; Cook WO; Soper KA; Nichols WW
    Carcinogenesis; 1995 Feb; 16(2):285-93. PubMed ID: 7859360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of E mu-PIM-1 transgenic mice short-term in vivo carcinogenicity testing: lymphoma induction by benzo[a]pyrene, but not by TPA.
    Kroese ED; Dortant PM; van Steeg H; van Oostrom CT; van der Houven van Oordt CW; van Kranen HJ; de Vries A; Wester PW; van Kreijl CF
    Carcinogenesis; 1997 May; 18(5):975-80. PubMed ID: 9163683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term carcinogenicity testing of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in E(mu)-pim-1 transgenic mice.
    Sørensen IK; Mortensen A; Kristiansen E; van Kreijl C; Adamson RH; Thorgeirsson SS
    Carcinogenesis; 1996 Oct; 17(10):2221-7. PubMed ID: 8895492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray-induced lymphomagenesis in E mu-pim-1 transgenic mice: an investigation of the co-operating molecular events.
    van der Houven van Oordt CW; Schouten TG; van Krieken JH; van Dierendonck JH; van der Eb AJ; Breuer ML
    Carcinogenesis; 1998 May; 19(5):847-53. PubMed ID: 9635873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoma induction by heterocyclic amines in E mu-pim-1 transgenic mice.
    Sørensen IK; Kristiansen E; Mortensen A; van Kreijl C; Adamson RH; Thorgeirsson SS
    Arch Toxicol Suppl; 1997; 19():377-86. PubMed ID: 9079225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
    Schmidt T; Karsunky H; Gau E; Zevnik B; Elsässer HP; Möröy T
    Oncogene; 1998 Nov; 17(20):2661-7. PubMed ID: 9840930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras.
    Breuer M; Wientjens E; Verbeek S; Slebos R; Berns A
    Cancer Res; 1991 Feb; 51(3):958-63. PubMed ID: 1988138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene.
    Schmidt T; Zörnig M; Beneke R; Möröy T
    Nucleic Acids Res; 1996 Jul; 24(13):2528-34. PubMed ID: 8692692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice.
    Yamamoto S; Mitsumori K; Kodama Y; Matsunuma N; Manabe S; Okamiya H; Suzuki H; Fukuda T; Sakamaki Y; Sunaga M; Nomura G; Hioki K; Wakana S; Nomura T; Hayashi Y
    Carcinogenesis; 1996 Nov; 17(11):2455-61. PubMed ID: 8968063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of DNA repair-deficient XPA transgenic mice in short-term carcinogenicity testing.
    van Steeg H; Klein H; Beems RB; van Kreijl CF
    Toxicol Pathol; 1998; 26(6):742-9. PubMed ID: 9864090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid carcinogenicity testing system with transgenic mice harboring human prototype c-HRAS gene.
    Yamamoto S; Hayashi Y; Mitsumori K; Nomura T
    Lab Anim Sci; 1997 Apr; 47(2):121-6. PubMed ID: 9150488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies.
    Mitsumori K; Koizumi H; Nomura T; Yamamoto S
    Toxicol Pathol; 1998; 26(4):520-31. PubMed ID: 9715511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to 60 Hz magnetic fields and risk of lymphoma in PIM transgenic and TSG-p53 (p53 knockout) mice.
    McCormick DL; Ryan BM; Findlay JC; Gauger JR; Johnson TR; Morrissey RL; Boorman GA
    Carcinogenesis; 1998 Sep; 19(9):1649-53. PubMed ID: 9771937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
    Möröy T; Verbeek S; Ma A; Achacoso P; Berns A; Alt F
    Oncogene; 1991 Nov; 6(11):1941-8. PubMed ID: 1658705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term exposure of E-mu-Pim1 transgenic mice to 898.4 MHz microwaves does not increase lymphoma incidence.
    Utteridge TD; Gebski V; Finnie JW; Vernon-Roberts B; Kuchel TR
    Radiat Res; 2002 Sep; 158(3):357-64. PubMed ID: 12175314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.
    Zörnig M; Schmidt T; Karsunky H; Grzeschiczek A; Möröy T
    Oncogene; 1996 Apr; 12(8):1789-801. PubMed ID: 8622900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic mice as a means to study synergism between oncogenes.
    Berns A; Breuer M; Verbeek S; van Lohuizen M
    Int J Cancer Suppl; 1989; 4():22-5. PubMed ID: 2681009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with haloperidol, reserpine, phenacetin, and D-mannitol.
    Lina BA; Woutersen RA; Bruijntjes JP; van Benthem J; van den Berg JA; Monbaliu J; Thoolen BJ; Beems RB; van Kreijl CF
    Toxicol Pathol; 2004; 32(2):192-201. PubMed ID: 15200157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.